Gastroenterology Research and Practice / 2016 / Article / Tab 1

Research Article

Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience

Table 1

General demographic data of hepatocellular carcinoma (HCC) patients.

Mean ± SD (%)

Age (years)65 ± 10
BMI27.6 ± 5.9
Gender
 (male : female)(2.5 : 1)
Male168 (71.50%)
Hypertension123 (52.30%)
Diabetes 136 (57.90%)
Dyslipidemia30 (12.80%)
Common symptoms
 Abdominal pain66 (28.10%)
 Abdominal distension 35 (14.90%)
 Anorexia 30 (12.80%)
 Fatigue 27 (11.50%)
 Weight loss 20 (8.50%)
 Jaundice18 (7.70%)
Underlying cause of liver disease
 Viral hepatitis178 (75.70%)
  (i)  HCV110 (46.80%)
  (ii)  HBV 62 (26.40%)
  (iii)  HBV + HCV6 (2.60%)
 Nonviral hepatitis57 (24.30%)
  (i)  Cryptogenic51 (21.70%)
  (ii)  Autoimmune3 (1.30%)
  (iii)  Schistosomiasis2 (0.90%)
  (iv)  Alcohol1 (0.40%)

SD: standard deviation; BMI: body mass index; HBV: hepatitis B virus; HCV: hepatitis C virus.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.